DivInc has launched its new female-focused accelerator and named its first cohort. Photo via Getty Images

DivInc, an Austin-based accelerator for women and people of color, announced today that it has launched its first Women in Tech HTX cohort in partnership with female-focused co-working space SheSpace.

The nine women-led companies will join DivInc's 11th cohort and the first to operate out of Houston. Founders will receive $10,000 in non-dilutive funding upon completion of a 12-week curriculum, which includes in-depth workshops that aim to help the founders "make a year's worth of progress in just three months," Amanda Moya, DivInc’s Houston program director, said in a statement.

According to DivInc, the aim of the accelerator is to support more female-led startups in the Houston area (which the company says it has seen an emergence of in the last two years) and connect them with its network of VCs.

Founders will be paired with mentors from Microsoft and Google to support their next phases of development. DivInc and SheSpace will also provide stipends for founders in need of childcare assistance.

A committee consisting of representatives from Mercury, Artemis Fund, Microsoft, and several other partners helped select the group of founders considering market size, scalability, industry need, and other factors.

Members of the fall cohort include:

Weekly workshops will take place at SheSpace, an all-women coworking space developed by Stephanie Tsuru that opened in the Heights in 2020. The accelerator is also supported by Houston Houston partners J.P. Morgan Chase & Co., Verizon, The Ion and Mercury.

DivInc will introduce the accepted companies at a happy hour on Thursday, Sept. 22 at The Ion. Those interested in attending can RSVP online.

"With several of these companies coming from outside of Texas, we’re looking forward to the founders making organic connections and learning more about what Houston has to offer," Moya added.

SheSpace will host the accelerator. Image via shespacehtx.com

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.